Nutranext Recalls Colon Cleansing Kit Peppermint Due to Lead Contamination
Nutranext Business LLC is recalling Colon Cleansing Kit Peppermint because routine testing found elevated lead levels that may pose health risks.
The agency’s classification
FDA (Food): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves lead contamination, which is a significant health hazard. Per the rubric, FDA Class II recalls with significant injury/property-damage reports or high-risk contaminants are rated Severe (4).
Plain-English summary
Nutranext Business LLC is voluntarily recalling 7,638 packages of Colon Cleansing Kit Peppermint. The recall was initiated after routine quality testing identified elevated levels of lead above applicable 2232 levels.
The product was distributed to US and foreign consignees. The affected batch numbers include SC728, SC725, SC720, SC714, SC712, SC697, SC679, SC651, SC648, SC642, SC640, SC610, SC624, SC617, SC600, SC609, SC599, SC601, SC595, SC571, SC545, SC515, and SC502.
Consumers should stop using the product and check their batch numbers against the list provided. The FDA classifies this as a Class II recall, indicating a reasonable probability that use of the product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Colon Cleansing Kit Peppermint
- Manufacturer
- NUTRANEXT BUSINESS LLC
- Category
- Food — Supplements
- Hazard
- Affected units
- 7,638
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 8 recalled by NUTRANEXT BUSINESS LLC under a single FDA (Food) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 8 products in this recall →Related recalls
Same manufacturer · NUTRANEXT BUSINESS LLC
See all →- HighNutranext Recalls Colon Cleansing Kit Ginger Due to Lead Levels
FDA (Food) · 2018-11-14
- HighNUTRANEXT Internal Cleansing Kit Peppermint Recalled for Elevated Lead Levels
FDA (Food) · 2018-11-14
- SevereNUTRANEXT Toxin Absorber Recalled for Elevated Lead Levels
FDA (Food) · 2018-11-14
- HighNutranext Recalls Parasite Cleansing Kit Ginger Due to Lead Contamination
FDA (Food) · 2018-11-14
- HighNutranext Toxin Absorber Peppermint Leaf Recalled for Elevated Lead Levels
FDA (Food) · 2018-11-14
Same hazard · lead contamination
See all →- HighLior Cinnamon Ground Seasoning Recalled for Elevated Lead Levels
FDA (Food) · 2026-10-07
- SevereNaproxen Oral Suspension Recalled for Lead and Lithium Contamination
FDA (Drugs) · 2026-05-13
- LowUSDA Retracts Lead Alert for Dorada Chicken Nuggets
USDA FSIS · 2026-04-06
- ModerateAluminum Kadai with Metal Handles Recalled Due to Potential Lead Contamination
FDA (Food) · 2026-02-25
- SevereIKM Aluminum Saucepan Recalled Over Lead Contamination Risk
FDA (Food) · 2026-02-25
Similar recalls
- ModeratePeppermint Antacid Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2022-02-16
- ModerateNutralox Peppermint Antacid Bulk Container Recalled for CGMP Deviations
FDA (Drugs) · 2022-02-16
- SeverePerrigo Recalls Ranitidine Tablets Due to Possible N-Nitrosodimethylamine Contamination
FDA (Drugs) · 2020-03-25
- HighCinnamon powder recalled over potentially elevated levels of lead
FDA (Food) · 2025-11-12
- HighSpice Class Brand Ground Cinnamon Recalled for Elevated Lead Levels
FDA (Food) · 2024-09-04
- ModerateSpearmint Antacid Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2022-02-16